These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20039125)

  • 41. Cardiac biomarkers are influenced by dialysis characteristics.
    Sommerer C; Heckele S; Schwenger V; Katus HA; Giannitsis E; Zeier M
    Clin Nephrol; 2007 Dec; 68(6):392-400. PubMed ID: 18184522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Is the N-terminal pro-B-type natriuretic peptide a predictor of cardiovascular events in hemodialysis patients?].
    Sedov DS; Fedotov EA; Rebrov AP
    Kardiologiia; 2020 Nov; 60(10):55-61. PubMed ID: 33228506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke.
    Tu WJ; Ma GZ; Ni Y; Hu XS; Luo DZ; Zeng XW; Liu Q; Xu T; Yu L; Wu B
    Neurology; 2017 May; 88(20):1899-1905. PubMed ID: 28424274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis.
    Etgen T; Baum H; Sander K; Sander D
    Stroke; 2005 Feb; 36(2):270-5. PubMed ID: 15604421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-Terminal Pro-B-Type Natriuretic Peptide Is Not a Significant Predictor of Stroke Incidence After 5 Years　- The Ohasama Study.
    Satoh M; Murakami T; Asayama K; Hirose T; Kikuya M; Inoue R; Tsubota-Utsugi M; Murakami K; Matsuda A; Hara A; Obara T; Kawasaki R; Nomura K; Metoki H; Node K; Imai Y; Ohkubo T
    Circ J; 2018 Jul; 82(8):2055-2062. PubMed ID: 29887544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between increased N-terminal pro-brain natriuretic peptide level and poor clinical outcomes after acute ischemic stroke.
    Yang J; Zhong C; Wang A; Xu T; Bu X; Peng Y; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J;
    J Neurol Sci; 2017 Dec; 383():5-10. PubMed ID: 29246621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients.
    Okute Y; Shoji T; Hayashi T; Kuwamura Y; Sonoda M; Mori K; Shioi A; Tsujimoto Y; Tabata T; Emoto M; Inaba M
    J Atheroscler Thromb; 2017 Apr; 24(4):412-421. PubMed ID: 27629255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis.
    Brueckmann M; Huhle G; Lang S; Haase KK; Bertsch T; Weiss C; Kaden JJ; Putensen C; Borggrefe M; Hoffmann U
    Circulation; 2005 Jul; 112(4):527-34. PubMed ID: 16027260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
    J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Admission NT-proBNP levels, renal insufficiency and age as predictors of mortality in elderly patients hospitalized for acute dyspnea.
    Reny JL; Millot O; Vanderecamer T; Vergnes C; Barazer I; Sedighian S; Berdagué P
    Eur J Intern Med; 2009 Jan; 20(1):14-9. PubMed ID: 19237086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal Functions and Prognosis Stratification in Chronic Heart Failure Patients and the Importance of Neutrophil Gelatinase-Associated Lipocalin.
    Lábr K; Špinar J; Pařenica J; Špinarová L; Málek F; Špinarová M; Ludka O; Jarkovský J; Benešová K; Goldbergová-Pávková M; Lábrová R
    Kidney Blood Press Res; 2018; 43(6):1865-1877. PubMed ID: 30537724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
    J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amino-terminal pro-B-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the Linz Peripheral Arterial Disease Study.
    Mueller T; Dieplinger B; Poelz W; Endler G; Wagner OF; Haltmayer M
    Clin Chem; 2009 Jan; 55(1):68-77. PubMed ID: 18988753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of a dialysis session on the prognostic values of NT-proBNP, troponins, endothelial damage and inflammation biomarkers.
    Codognotto M; Piccoli A; Zaninotto M; Mion MM; Ruzza L; Barchita A; Naso A; Plebani M
    J Nephrol; 2010; 23(4):465-71. PubMed ID: 20540041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.
    Obokata M; Sunaga H; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
    Am Heart J; 2016 Sep; 179():29-41. PubMed ID: 27595677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
    Ouanes I; Jalloul F; Ayed S; Dachraoui F; Ouanes-Besbes L; Fekih Hassen M; Elatrous S; Abroug F
    Respirology; 2012 May; 17(4):660-6. PubMed ID: 22348741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.